Gene · 3670
Papers3,753
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,753
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The LIM Protein AJUBA is a Potential Oncogenic Target and Prognostic Marker in Human Cancer via Pan-Cancer Analysis. | Front Cell Dev Biol | 2022 | 35898403 | PubTator, text mining | PubMed |
| Paracrine Factors Released by Stem Cells of Mesenchymal Origin and their Effects in Cardiovascular Disease: A Systematic Review of Pre-clinical Studies. | Stem Cell Rev Rep | 2022 | 35896860 | PubTator, text mining | PubMed |
| Artificial Scaffolds in Cardiac Tissue Engineering. | Life (Basel) | 2022 | 35892919 | PubTator, text mining | PubMed |
| Targeted-Deletion of a Tiny Sequence via Prime Editing to Restore SMN Expression. | Int J Mol Sci | 2022 | 35887289 | PubTator, text mining | PubMed |
| An Integrated Bioinformatics Analysis towards the Identification of Diagnostic, Prognostic, and Predictive Key Biomarkers for Urinary Bladder Cancer. | Cancers (Basel) | 2022 | 35884419 | PubTator, text mining | PubMed |
| Pancreatic Transdifferentiation Using β-Cell Transcription Factors for Type 1 Diabetes Treatment. | Cells | 2022 | 35883588 | PubTator, text mining | PubMed |
| Atypically Shaped Cardiomyocytes (ACMs): The Identification, Characterization and New Insights into a Subpopulation of Cardiomyocytes. | Biomolecules | 2022 | 35883452 | PubTator, text mining | PubMed |
| The Ldb1 transcriptional co-regulator is required for establishment and maintenance of the pancreatic endocrine lineage. | FASEB J | 2022 | 35881062 | PubTator, text mining | PubMed |
| Rapid 3D-STORM imaging of diverse molecular targets in tissue. | Cell Rep Methods | 2022 | 35880013 | PubTator, text mining | PubMed |
| Cellular analysis of SOD1 protein-aggregation propensity and toxicity: a case of ALS with slow progression harboring homozygous SOD1-D92G mutation. | Sci Rep | 2022 | 35879519 | PubTator, text mining | PubMed |
| Presentation and diagnosis of childhood-onset combined pituitary hormone deficiency: A single center experience from over 30 years. | EClinicalMedicine | 2022 | 35875813 | PubTator, text mining | PubMed |
| Application of Small Molecules in the Central Nervous System Direct Neuronal Reprogramming. | Front Bioeng Biotechnol | 2022 | 35875485 | PubTator, text mining | PubMed |
| Study of variants associated with ventricular septal defects (VSDs) highlights the unique genetic structure of the Pakistani population. | Ital J Pediatr | 2022 | 35870951 | PubTator, text mining | PubMed |
| P97/VCP ATPase inhibitors can rescue p97 mutation-linked motor neuron degeneration. | Brain Commun | 2022 | 35865348 | PubTator, text mining | PubMed |
| Moxifloxacin rescues SMA phenotypes in patient-derived cells and animal model. | Cell Mol Life Sci | 2022 | 35864358 | PubTator, text mining | PubMed |
| Fine-tuned KDM1A alternative splicing regulates human cardiomyogenesis through an enzymatic-independent mechanism. | iScience | 2022 | 35856020 | PubTator, text mining | PubMed |
| Single-cell multiomics analysis reveals regulatory programs in clear cell renal cell carcinoma. | Cell Discov | 2022 | 35853872 | PubTator, text mining | PubMed |
| RA signaling pathway combined with Wnt signaling pathway regulates human-induced pluripotent stem cells (hiPSCs) differentiation to sinus node-like cells. | Stem Cell Res Ther | 2022 | 35851424 | PubTator, text mining | PubMed |
| Stem cells differentiation into insulin-producing cells (IPCs): recent advances and current challenges. | Stem Cell Res Ther | 2022 | 35840987 | PubTator, text mining | PubMed |
| ALOX12: A Novel Insight in Bevacizumab Response, Immunotherapy Effect, and Prognosis of Colorectal Cancer. | Front Immunol | 2022 | 35833141 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3670/papers?page=36